Novel Protein Target for Alzheimer’s Therapy Is Studied

Heparan-sulfate-modified proteins, or proteoglycans (HSPGs), may be a useful early-stage target for novel treatments for Alzheimer’s disease, according to research led by Pennsylvania State University. Up to seven million Americans suffer with Alzheimer’s disease, a neurological condition that is steadily on the rise. The majority Continue Reading